QIAGEN appoints Jonathan M. Pratt as CEO

QIAGEN has announced the appointment of Jonathan M. Pratt as Chief Executive Officer, effective September 1, 2026. Pratt, who brings over 25 years of leadership experience in life sciences and laboratory technologies, previously served as President and CEO of Filtration Group.

Following the appointment, Pratt will be proposed for election as Managing Director at an extraordinary general meeting scheduled for the fourth quarter of 2026. The current CEO, Thierry Bernard, will step down from his roles as Chairman and Managing Director, remaining with the company through the end of the year to ensure an orderly transition.

In conjunction with this leadership change, QIAGEN reaffirmed its financial outlook for the third quarter and the full year of 2026. The company stated it remains focused on achieving profitable growth through operational efficiency and the development of its growth drivers.